The opening question of our work was to determine whether CXCL13 could trigger B-cell recruitment to peripheral organs and lead to ectopic GC development, such as observed in tertiary lymphoid tissues, such as in the thymus of MG patients. Here, CXCL13 is linked to myasthenia gravis.